10X Genomics
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
| Revenue | $141,006 | $183,979 | $153,644 | $146,819 |
| Gross Profit | 95,569 | 106,065 | 95,529 | 99,612 |
| EBITDA | -47,904 | -23,904 | -91,743 | -60,762 |
| EBIT | -59,398 | -35,610 | -94,795 | -72,639 |
| Net Income | -59,949 | -48,952 | -92,986 | -62,414 |
| Net Change In Cash | 141,006 | 183,979 | 153,644 | 146,819 |
| Cost of Revenue | -8,892 | |||
| Free Cash Flow | -18,635 | 22,308 | -40,740 | -36,882 |
| Cash | 355,781 | 359,284 | 311,264 | 325,879 |
| Basic Shares | 119,394 | 118,565 | 117,728 | 116,707 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Revenue | $618,727 | $516,409 | $490,490 | $298,845 |
| Gross Profit | 409,313 | 396,023 | 416,399 | 240,377 |
| EBITDA | -158,249 | -161,495 | -53,509 | -82,455 |
| EBIT | -201,868 | -167,944 | -52,913 | -85,324 |
| Net Income | -255,099 | -166,000 | -58,223 | -542,731 |
| Net Change In Cash | 618,727 | 516,409 | 490,490 | 298,845 |
| Cost of Revenue | -368,676 | -92,805 | 212,614 | |
| Free Cash Flow | -64,721 | -165,267 | -122,651 | -256,292 |
| Cash | 359,284 | 219,746 | 587,447 | 663,603 |
| Basic Shares | 117,165 | 113,858 | 110,347 | 101,151 |
Earnings Calls
| Quarter | EPS |
|---|---|
| 2024-03-31 | -$0.50 |
| 2023-12-31 | -$0.41 |
| 2023-09-30 | -$0.79 |
| 2023-06-30 | -$0.53 |
